XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.22.2

3. Intangible Assets, Goodwill and Other | 6 Months Ended
--- | ---
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets Disclosure | GOODWILL AND OTHER PURCHASED INTANGIBLE ASSETS Goodwill by segment are as follows (in millions):
| Life Science |  | Clinical Diagnostics |  | Total
Balances as of June 30, 2022 and December 31, 2021: |  |  |  |  |
Goodwill | $ | 333.3 |  |  | $ | 349.2 |  |  | $ | 682.5 |
Accumulated impairment losses | (41.8) |  |  | (293.4) |  |  | (335.2) |
Goodwill, net | $ | 291.5 |  |  | $ | 55.8 |  |  | $ | 347.3 |
Information regarding our identifiable purchased intangible assets with finite and indefinite lives is as follows (in millions):
| June 30, 2022
| Weighted-Average Remaining Amortization Period (years) |  | Purchase Price |  | Accumulated Amortization |  | Net Carrying Amount
Customer relationships/lists | 5.15 |  | $ | 106.3 |  |  | $ | (88.7) |  |  | $ | 17.6 |
Know how | 3.25 |  | 164.4 |  |  | (149.9) |  |  | 14.5 |
Developed product technology | 13.17 |  | 210.6 |  |  | (116.4) |  |  | 94.2 |
Licenses | 6.33 |  | 58.8 |  |  | (36.5) |  |  | 22.3 |
Tradenames | 7.02 |  | 6.1 |  |  | (4.3) |  |  | 1.8 |
Covenants not to compete | 3.42 |  | 6.4 |  |  | (3.4) |  |  | 3.0 |
Total finite-lived intangible assets |  |  | 552.6 |  |  | (399.2) |  |  | 153.4 |
In-process research and development |  |  | 86.3 |  |  | — |  |  | 86.3 |
Total purchased intangible assets |  |  | $ | 638.9 |  |  | $ | (399.2) |  |  | $ | 239.7 |
| December 31, 2021
| Weighted-Average Remaining Amortization Period (years) |  | Purchase Price |  | Accumulated Amortization |  | Net Carrying Amount
Customer relationships/lists | 5.27 |  | $ | 111.8 |  |  | $ | (90.7) |  |  | $ | 21.1 |
Know how | 3.75 |  | 171.6 |  |  | (154.9) |  |  | 16.7 |
Developed product technology | 13.42 |  | 215.6 |  |  | (115.6) |  |  | 100.0 |
Licenses | 6.79 |  | 64.9 |  |  | (40.6) |  |  | 24.3 |
Tradenames | 7.33 |  | 6.3 |  |  | (4.4) |  |  | 1.9 |
Covenants not to compete | 3.78 |  | 6.5 |  |  | (2.9) |  |  | 3.6 |
Total finite-lived intangible assets |  |  | 576.7 |  |  | (409.1) |  |  | 167.6 |
In-process research and development |  |  | 86.3 |  |  | — |  |  | 86.3 |
Total purchased intangible assets |  |  | $ | 663.0 |  |  | $ | (409.1) |  |  | $ | 253.9 |
Amortization expense related to purchased intangible assets is as follows (in millions):
| Three Months Ended |  | Six Months Ended
| June 30, |  | June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Amortization expense | $ | 6.3 |  |  | $ | 7.2 |  |  | $ | 12.6 |  |  | $ | 14.4 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI https://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration